Possible Mechanisms and Molecular Signaling of Incretins against the Development of Type 2 Diabetes Mellitus

Kibel, A.; Selthofer-Relatic, K.; Drenjancevic, I.; Bacun, T.; Bosnjak, I.; Kibel, D.; Gros, M. Coronary microvascular dysfunction in diabetes mellitus. J. Int. Med. Res., 2017, 45(6), 1901-1929.
[http://dx.doi.org/10.1177/0300060516675504] [PMID: 28643578]

Atlas, D. International diabetes federation, IDF Diabetes Atlas, 7th ed; International Diabetes Federation: Brussels, Belgium, 2015.

Cho, N.H.; Shaw, J.E.; Karuranga, S.; Huang, Y.; da Rocha Fernandes, J.D.; Ohlrogge, A.W.; Malanda, B. IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract., 2018, 138, 271-281.
[http://dx.doi.org/10.1016/j.diabres.2018.02.023] [PMID: 29496507]

Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature, 2001, 414(6865), 813-820.
[http://dx.doi.org/10.1038/414813a] [PMID: 11742414]

Nickerson, H.D.; Dutta, S. Diabetic complications: Current challenges and opportunities. J. Cardiovasc. Transl. Res., 2012, 5(4), 375-379.
[http://dx.doi.org/10.1007/s12265-012-9388-1] [PMID: 22752737]

Papatheodorou, K.; Banach, M.; Bekiari, E.; Rizzo, M.; Edmonds, M. Complications of diabetes 2017; Hindawi, 2018.
[http://dx.doi.org/10.1155/2018/3086167]

Sloan, L.A. Review of glucagon‐like peptide‐1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effects. J. Diabetes, 2019, 11(12), 938-948.
[http://dx.doi.org/10.1111/1753-0407.12969] [PMID: 31318152]

Nathan, D.M.; Genuth, S.; Lachin, J.; Cleary, P.; Crofford, O.; Davis, M.; Rand, L.; Siebert, C. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med., 1993, 329(14), 977-986.
[http://dx.doi.org/10.1056/NEJM199309303291401] [PMID: 8366922]

Kahn, S.E.; Cooper, M.E.; Del Prato, S. Pathophysiology and treatment of type 2 diabetes: Perspectives on the past, present, and future. Lancet, 2014, 383(9922), 1068-1083.
[http://dx.doi.org/10.1016/S0140-6736(13)62154-6] [PMID: 24315620]

Groeneveld, O.N.; Kappelle, L.J.; Biessels, G.J. Potentials of incretin‐based therapies in dementia and stroke in type 2 diabetes mellitus. J. Diabetes Investig., 2016, 7(1), 5-16.
[http://dx.doi.org/10.1111/jdi.12420] [PMID: 26816596]

Nauck, M.A.; Meier, J.J. Incretin hormones: Their role in health and disease. Diabetes Obes. Metab., 2018, 20(Suppl. 1), 5-21.
[http://dx.doi.org/10.1111/dom.13129] [PMID: 29364588]

Drucker, D.J.; Nauck, M.A. The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet, 2006, 368(9548), 1696-1705.
[http://dx.doi.org/10.1016/S0140-6736(06)69705-5] [PMID: 17098089]

Gooßen, K.; Gräber, S. Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: Systematic review and meta-analysis. Diabetes Obes. Metab., 2012, 14(12), 1061-1072.
[http://dx.doi.org/10.1111/j.1463-1326.2012.01610.x] [PMID: 22519906]

Campbell, J.E.; Drucker, D.J. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab., 2013, 17(6), 819-837.
[http://dx.doi.org/10.1016/j.cmet.2013.04.008] [PMID: 23684623]

Nauck, M.A.; Meier, J.J. The incretin effect in healthy individuals and those with type 2 diabetes: Physiology, pathophysiology, and response to therapeutic interventions. Lancet Diabetes Endocrinol., 2016, 4(6), 525-536.
[http://dx.doi.org/10.1016/S2213-8587(15)00482-9] [PMID: 26876794]

DeFronzo, R.A. Banting Lecture. From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus. Diabetes, 2009, 58(4), 773-795.
[http://dx.doi.org/10.2337/db09-9028] [PMID: 19336687]

Tasyurek, H.M.; Altunbas, H.A.; Balci, M.K.; Sanlioglu, S. Incretins: Their physiology and application in the treatment of diabetes mellitus. Diabetes Metab. Res. Rev., 2014, 30(5), 354-371.
[http://dx.doi.org/10.1002/dmrr.2501] [PMID: 24989141]

Holz, G.G. Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. Diabetes, 2004, 53(1), 5-13.
[http://dx.doi.org/10.2337/diabetes.53.1.5] [PMID: 14693691]

Oh, Y.; Jun, H.S. Effects of glucagon-like peptide-1 on oxidative stress and Nrf2 signaling. Int. J. Mol. Sci., 2017, 19(1), 26.
[http://dx.doi.org/10.3390/ijms19010026] [PMID: 29271910]

Xie, Z.; Enkhjargal, B.; Wu, L.; Zhou, K.; Sun, C.; Hu, X.; Gospodarev, V.; Tang, J.; You, C.; Zhang, J.H. Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats. Neuropharmacology, 2018, 128, 142-151.
[http://dx.doi.org/10.1016/j.neuropharm.2017.09.040] [PMID: 28986282]

Gao, L.; Li, S.L.; Li, Y.K. Liraglutide promotes the osteogenic differentiation in MC3T3-E1 Cells via regulating the expression of Smad2/3 through PI3K/Akt and Wnt/β-catenin pathways. DNA Cell Biol., 2018, 37(12), 1031-1043.
[http://dx.doi.org/10.1089/dna.2018.4397] [PMID: 30403540]

Andreozzi, F.; Raciti, G.A.; Nigro, C.; Mannino, G.C.; Procopio, T.; Davalli, A.M.; Beguinot, F.; Sesti, G.; Miele, C.; Folli, F. The GLP-1 receptor agonists exenatide and liraglutide activate glucose transport by an AMPK-dependent mechanism. J. Transl. Med., 2016, 14(1), 229.
[http://dx.doi.org/10.1186/s12967-016-0985-7] [PMID: 27473212]

Seino, Y.; Fukushima, M.; Yabe, D. GIP and GLP-1, the two incretin hormones: Similarities and differences. J. Diabetes Investig., 2010, 1(1-2), 8-23.
[http://dx.doi.org/10.1111/j.2040-1124.2010.00022.x] [PMID: 24843404]

Nauck, M.A. Incretin-based therapies for type 2 diabetes mellitus: Properties, functions, and clinical implications. Am. J. Med., 2011, 124(1), S3-S18.
[http://dx.doi.org/10.1016/j.amjmed.2010.11.002] [PMID: 21194578]

Baggio, L.L.; Drucker, D.J. Biology of incretins: GLP-1 and GIP. Gastroenterology, 2007, 132(6), 2131-2157.
[http://dx.doi.org/10.1053/j.gastro.2007.03.054] [PMID: 17498508]

Seino, Y.; Yabe, D. Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas. J. Diabetes Investig., 2013, 4(2), 108-130.
[http://dx.doi.org/10.1111/jdi.12065] [PMID: 24843641]

Chia, C.W.; Carlson, O.D.; Kim, W.; Shin, Y-K.; Charles, C.P.; Kim, H.S.; Melvin, D.L.; Egan, J.M. Exogenous glucose–dependent insulinotropic polypeptide worsens post prandial hyperglycemia in Type 2 diabetes. Diabetes, 2009, 58(6), 1342-1349.

Mulvihill, E.E.; Drucker, D.J. Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors. Endocr. Rev., 2014, 35(6), 992-1019.
[http://dx.doi.org/10.1210/er.2014-1035] [PMID: 25216328]

Mima, A. Incretin-based therapy for prevention of diabetic vascular complications. J. Diabetes Res., 2016, 2016, 1-12.
[http://dx.doi.org/10.1155/2016/1379274] [PMID: 26881236]

González, C.; Beruto, V.; Keller, G.; Santoro, S.; Di Girolamo, G. Investigational treatments for Type 2 diabetes mellitus: Exenatide and liraglutide. Expert Opin. Investig. Drugs, 2006, 15(8), 887-895.
[http://dx.doi.org/10.1517/13543784.15.8.887] [PMID: 16859392]

Deacon, C.F.; Ahrén, B.; Holst, J.J. Inhibitors of dipeptidyl peptidase IV: A novel approach for the prevention and treatment of type 2 diabetes? Expert Opin. Investig. Drugs, 2004, 13(9), 1091-1102.
[http://dx.doi.org/10.1517/13543784.13.9.1091] [PMID: 15330741]

Samson, S.L.; Garber, A. GLP-1R agonist therapy for diabetes. Curr. Opin. Endocrinol. Diabetes Obes., 2013, 20(2), 87-97.
[http://dx.doi.org/10.1097/MED.0b013e32835edb32] [PMID: 23403741]

Forst, T.; Weber, M.M.; Pfützner, A. Cardiovascular benefits of GLP-1-based herapies in patients with diabetes mellitus type 2: Effects on endothelial and vascular dysfunction beyond glycemic control. Exp. Diabetes Res., 2012, 2012, 1-9.
[http://dx.doi.org/10.1155/2012/635472] [PMID: 22577369]

Davies, M.; Pratley, R.; Hammer, M.; Thomsen, A.B.; Cuddihy, R. Liraglutide improves treatment satisfaction in people with Type 2 diabetes compared with sitagliptin, each as an add on to metformin. Diabet. Med., 2011, 28(3), 333-337.
[PMID: 21309842]

Pratley, R.; Nauck, M.; Bailey, T.; Montanya, E.; Cuddihy, R.; Filetti, S.; Garber, A.; Thomsen, A.B.; Hartvig, H.; Davies, M. One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: A randomised, parallel-group, open-label trial. Int. J. Clin. Pract., 2011, 65(4), 397-407.
[http://dx.doi.org/10.1111/j.1742-1241.2011.02656.x] [PMID: 21355967]

Peyrot, M.; Rubin, R.R. How does treatment satisfaction work?: Modeling determinants of treatment satisfaction and preference. Diabetes Care, 2009, 32(8), 1411-1417.
[http://dx.doi.org/10.2337/dc08-2256] [PMID: 19470837]

Buse, J.B.; Garber, A.; Rosenstock, J.; Schmidt, W.E.; Brett, J.H.; Videbæk, N.; Holst, J.; Nauck, M. Liraglutide treatment is associated with a low frequency and magnitude of antibody formation with no apparent impact on glycemic response or increased frequency of adverse events: Results from the Liraglutide Effect and Action in Diabetes (LEAD) trials. J. Clin. Endocrinol. Metab., 2011, 96(6), 1695-1702.
[http://dx.doi.org/10.1210/jc.2010-2822] [PMID: 21450987]

Buse, J.B.; Rosenstock, J.; Sesti, G.; Schmidt, W.E.; Montanya, E.; Brett, J.H.; Zychma, M.; Blonde, L. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: A 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet, 2009, 374(9683), 39-47.
[http://dx.doi.org/10.1016/S0140-6736(09)60659-0] [PMID: 19515413]

Duez, H.; Cariou, B.; Staels, B. DPP-4 inhibitors in the treatment of type 2 diabetes. Biochem. Pharmacol., 2012, 83(7), 823-832.
[http://dx.doi.org/10.1016/j.bcp.2011.11.028] [PMID: 22172989]

Marguet, D.; Baggio, L.; Kobayashi, T.; Bernard, A.M.; Pierres, M.; Nielsen, P.F.; Ribel, U.; Watanabe, T.; Drucker, D.J.; Wagtmann, N. Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc. Natl. Acad. Sci. USA, 2000, 97(12), 6874-6879.
[http://dx.doi.org/10.1073/pnas.120069197] [PMID: 10823914]

Conarello, S.L.; Li, Z.; Ronan, J.; Roy, R.S.; Zhu, L.; Jiang, G.; Liu, F.; Woods, J.; Zycband, E.; Moller, D.E.; Thornberry, N.A.; Zhang, B.B. Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance. Proc. Natl. Acad. Sci. USA, 2003, 100(11), 6825-6830.
[http://dx.doi.org/10.1073/pnas.0631828100] [PMID: 12748388]

Best, J.H.; Hoogwerf, B.J.; Herman, W.H.; Pelletier, E.M.; Smith, D.B.; Wenten, M.; Hussein, M.A. Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: A retrospective analysis of the LifeLink database. Diabetes Care, 2011, 34(1), 90-95.
[http://dx.doi.org/10.2337/dc10-1393] [PMID: 20929995]

Sokos, G.G.; Bolukoglu, H.; German, J.; Hentosz, T.; Magovern, G.J., Jr; Maher, T.D.; Dean, D.A.; Bailey, S.H.; Marrone, G.; Benckart, D.H.; Elahi, D.; Shannon, R.P. Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting. Am. J. Cardiol., 2007, 100(5), 824-829.
[http://dx.doi.org/10.1016/j.amjcard.2007.05.022] [PMID: 17719327]

Scott, K.A.; Moran, T.H. The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2007, 293(3), R983-R987.
[http://dx.doi.org/10.1152/ajpregu.00323.2007] [PMID: 17581835]

Meier, J.J. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nat. Rev. Endocrinol., 2012, 8(12), 728-742.
[http://dx.doi.org/10.1038/nrendo.2012.140] [PMID: 22945360]

Yamagishi, S.; Matsui, T. Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxid. Med. Cell. Longev., 2010, 3(2), 101-108.
[http://dx.doi.org/10.4161/oxim.3.2.11148] [PMID: 20716934]

Folli, F.; Corradi, D.; Fanti, P.; Davalli, A.; Paez, A.; Giaccari, A.; Perego, C.; Muscogiuri, G. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: Avenues for a mechanistic-based therapeutic approach. Curr. Diabetes Rev., 2011, 7(5), 313-324.
[http://dx.doi.org/10.2174/157339911797415585] [PMID: 21838680]

Naudi, A.; Jove, M.; Ayala, V.; Cassanye, A.; Serrano, J.; Gonzalo, H.; Boada, J.; Prat, J.; Portero-Otin, M.; Pamplona, R. Cellular dysfunction in diabetes as maladaptive response to mitochondrial oxidative stress. Exp. Diabetes Res., 2012, 2012, 1-14.
[http://dx.doi.org/10.1155/2012/696215] [PMID: 22253615]

Chang, G.; Liu, J.; Qin, S.; Jiang, Y.; Zhang, P.; Yu, H.; Lu, K.; Zhang, N.; Cao, L.; Wang, Y.; Li, Y.; Zhang, D. Cardioprotection by exenatide: A novel mechanism via improving mitochondrial function involving the GLP-1 receptor/cAMP/PKA pathway. Int. J. Mol. Med., 2018, 41(3), 1693-1703.
[PMID: 29286061]

Furman, B.; Ong, W.K.; Pyne, N.J. Cyclic AMP signaling in pancreatic islets, The Islets of Langerhans; Springer, 2010, pp. 281-304.

Kawanami, D.; Matoba, K.; Sango, K.; Utsunomiya, K. Incretin-based therapies for diabetic complications: Basic mechanisms and clinical evidence. Int. J. Mol. Sci., 2016, 17(8), 1223.
[http://dx.doi.org/10.3390/ijms17081223] [PMID: 27483245]

Yang, H.; Yang, L. Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy. J. Mol. Endocrinol., 2016, 57(2), R93-R108.
[http://dx.doi.org/10.1530/JME-15-0316] [PMID: 27194812]

Shao, W.; Wang, Z.; Ip, W.; Chiang, Y.T.; Xiong, X.; Chai, T.; Xu, C.; Wang, Q.; Jin, T. GLP-1(28–36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro. Am. J. Physiol. Endocrinol. Metab., 2013, 304(12), E1263-E1272.
[http://dx.doi.org/10.1152/ajpendo.00600.2012] [PMID: 23571712]

Fatrai, S.; Elghazi, L.; Balcazar, N.; Cras-Méneur, C.; Krits, I.; Kiyokawa, H.; Bernal-Mizrachi, E. Akt induces β-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes, 2006, 55(2), 318-325.
[http://dx.doi.org/10.2337/diabetes.55.02.06.db05-0757] [PMID: 16443763]

Satoh, M.; Fujimoto, S.; Haruna, Y.; Arakawa, S.; Horike, H.; Komai, N.; Sasaki, T.; Tsujioka, K.; Makino, H.; Kashihara, N. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am. J. Physiol. Renal Physiol., 2005, 288(6), F1144-F1152.
[http://dx.doi.org/10.1152/ajprenal.00221.2004] [PMID: 15687247]

Kim, J.S.; Diebold, B.A.; Babior, B.M.; Knaus, U.G.; Bokoch, G.M. Regulation of Nox1 activity via protein kinase A-mediated phosphorylation of NoxA1 and 14-3-3 binding. J. Biol. Chem., 2007, 282(48), 34787-34800.
[http://dx.doi.org/10.1074/jbc.M704754200] [PMID: 17913709]

Brown, J.A.; Diggs-Andrews, K.A.; Gianino, S.M.; Gutmann, D.H. Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner. Mol. Cell. Neurosci., 2012, 49(1), 13-22.
[http://dx.doi.org/10.1016/j.mcn.2011.08.008] [PMID: 21903164]

Wang, D.; Luo, P.; Wang, Y.; Li, W.; Wang, C.; Sun, D.; Zhang, R.; Su, T.; Ma, X.; Zeng, C.; Wang, H.; Ren, J.; Cao, F. Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism. Diabetes, 2013, 62(5), 1697-1708.
[http://dx.doi.org/10.2337/db12-1025] [PMID: 23364453]

Tang, S.; Tang, H.; Su, H.; Wang, Y.; Zhou, Q.; Zhang, Q.; Wang, Y.; Zhu, H. Glucagon-like peptide-1 attenuates endothelial barrier injury in diabetes via cAMP/PKA mediated down-regulation of MLC phosphorylation. Biomed. Pharmacother., 2019, 113, 108667.
[http://dx.doi.org/10.1016/j.biopha.2019.108667] [PMID: 30852419]

Erdogdu, Ö.; Nathanson, D.; Sjöholm, Å; Nyström, T.; Zhang, Q. Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor. Mol. Cell. Endocrinol., 2010, 325(1-2), 26-35.
[http://dx.doi.org/10.1016/j.mce.2010.04.022] [PMID: 20452396]

Bao, Y.; Jiang, L.; Chen, H.; Zou, J.; Liu, Z.; Shi, Y. The neuroprotective effect of liraglutide is mediated by glucagon-like peptide 1 receptor-mediated activation of cAMP/PKA/CREB Pathway. Cell. Physiol. Biochem., 2015, 36(6), 2366-2378.

Zhang, Y.; Ding, Y.; Zhong, X.; Guo, Q.; Wang, H.; Gao, J.; Bai, T.; Ren, L.; Guo, Y.; Jiao, X.; Liu, Y. Geniposide acutely stimulates insulin secretion in pancreatic β-cells by regulating GLP-1 receptor/cAMP signaling and ion channels. Mol. Cell. Endocrinol., 2016, 430, 89-96.
[http://dx.doi.org/10.1016/j.mce.2016.04.020] [PMID: 27126219]

Yanagimachi, T.; Fujita, Y.; Takeda, Y.; Honjo, J.; Sakagami, H.; Kitsunai, H.; Takiyama, Y.; Abiko, A.; Makino, Y.; Kieffer, T.J.; Haneda, M. Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects. Mol. Metab., 2017, 6(2), 226-231.
[http://dx.doi.org/10.1016/j.molmet.2016.12.009] [PMID: 28180064]

Lee, T.M.; Chen, W.T.; Chang, N.C. Dipeptidyl peptidase-4 inhibition attenuates arrhythmias via a protein kinase A-dependent pathway in infarcted hearts. Circulation, 2015, 79(11), 2461-2470.

Williams, M.D.; Nadler, J.L. Inflammatory mechanisms of diabetic complications. Curr. Diab. Rep., 2007, 7(3), 242-248.
[http://dx.doi.org/10.1007/s11892-007-0038-y] [PMID: 17547842]

Tsalamandris, S.; Antonopoulos, A.S.; Oikonomou, E.; Papamikroulis, G.A.; Vogiatzi, G.; Papaioannou, S.; Deftereos, S.; Tousoulis, D. The role of inflammation in diabetes: Current concepts and future perspectives. Eur. Cardiol., 2019, 14(1), 50-59.
[http://dx.doi.org/10.15420/ecr.2018.33.1] [PMID: 31131037]

Jin, H.Y.; Park, T.S. Role of inflammatory biomarkers in diabetic peripheral neuropathy. J. Diabetes Investig., 2018, 9(5), 1016-1018.
[http://dx.doi.org/10.1111/jdi.12794] [PMID: 29277966]

Rübsam, A.; Parikh, S.; Fort, P. Role of inflammation in diabetic retinopathy. Int. J. Mol. Sci., 2018, 19(4), 942.
[http://dx.doi.org/10.3390/ijms19040942] [PMID: 29565290]

Navarro-González, J.F.; Mora-Fernández, C.; de Fuentes, M.M.; García-Pérez, J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat. Rev. Nephrol., 2011, 7(6), 327-340.
[http://dx.doi.org/10.1038/nrneph.2011.51] [PMID: 21537349]

Que, Q.; Guo, X.; Zhan, L.; Chen, S.; Zhang, Z.; Ni, X.; Ye, B.; Wan, S. The GLP-1 agonist, liraglutide, ameliorates inflammation through the activation of the PKA/CREB pathway in a rat model of knee osteoarthritis. J. Inflamm. (Lond.), 2019, 16(1), 13.
[http://dx.doi.org/10.1186/s12950-019-0218-y] [PMID: 31182934]

Cohen, P. The TLR and IL-1 signalling network at a glance. J. Cell Sci., 2014, 127(Pt 11), 2383-2390.
[http://dx.doi.org/10.1242/jcs.149831]

Chaudhuri, A.; Umpierrez, G.E. Oxidative stress and inflammation in hyperglycemic crises and resolution with insulin: Implications for the acute and chronic complications of hyperglycemia. J. Diabetes Complications, 2012, 26(4), 257-258.
[http://dx.doi.org/10.1016/j.jdiacomp.2012.04.016] [PMID: 22658407]

Rains, J.L.; Jain, S.K. Oxidative stress, insulin signaling, and diabetes. Free Radic. Biol. Med., 2011, 50(5), 567-575.
[http://dx.doi.org/10.1016/j.freeradbiomed.2010.12.006] [PMID: 21163346]

Soysal, P.; Isik, A.T.; Carvalho, A.F.; Fernandes, B.S.; Solmi, M.; Schofield, P.; Veronese, N.; Stubbs, B. Oxidative stress and frailty: A systematic review and synthesis of the best evidence. Maturitas, 2017, 99, 66-72.
[http://dx.doi.org/10.1016/j.maturitas.2017.01.006] [PMID: 28364871]

Reuter, S.; Gupta, S.C.; Chaturvedi, M.M.; Aggarwal, B.B. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic. Biol. Med., 2010, 49(11), 1603-1616.
[http://dx.doi.org/10.1016/j.freeradbiomed.2010.09.006] [PMID: 20840865]

Tiedge, M.; Lortz, S.; Drinkgern, J.; Lenzen, S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes, 1997, 46(11), 1733-1742.
[http://dx.doi.org/10.2337/diab.46.11.1733] [PMID: 9356019]

Fiorentino, T.; Prioletta, A.; Zuo, P.; Folli, F. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr. Pharm. Des., 2013, 19(32), 5695-5703.
[http://dx.doi.org/10.2174/1381612811319320005] [PMID: 23448484]

Li, N.; Alam, J.; Venkatesan, M.I.; Eiguren-Fernandez, A.; Schmitz, D.; Di Stefano, E.; Slaughter, N.; Killeen, E.; Wang, X.; Huang, A.; Wang, M.; Miguel, A.H.; Cho, A.; Sioutas, C.; Nel, A.E. Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: Protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicals. J. Immunol., 2004, 173(5), 3467-3481.
[http://dx.doi.org/10.4049/jimmunol.173.5.3467] [PMID: 15322212]

Xiong, L.; Xie, J.; Song, C.; Liu, J.; Zheng, J.; Liu, C.; Zhang, X.; Li, P.; Wang, F. The activation of Nrf2 and its downstream regulated genes mediates the antioxidative activities of xueshuan xinmaining tablet in human umbilical vein endothelial cells. Evid. Based Complement. Alternat. Med., 2015, 2015, 1-7.
[http://dx.doi.org/10.1155/2015/187265] [PMID: 26681964]

Ahmed, S.M.U.; Luo, L.; Namani, A.; Wang, X.J.; Tang, X. Nrf2 signaling pathway: Pivotal roles in inflammation. Biochim. Biophys. Acta Mol. Basis Dis., 2017, 1863(2), 585-597.
[http://dx.doi.org/10.1016/j.bbadis.2016.11.005] [PMID: 27825853]

Abdelsalam, R.M.; Safar, M.M. Neuroprotective effects of vildagliptin in rat rotenone Parkinson’s disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways. J. Neurochem., 2015, 133(5), 700-707.
[http://dx.doi.org/10.1111/jnc.13087] [PMID: 25752913]

Tamtaji, O.R.; Naderi Taheri, M.; Notghi, F.; Alipoor, R.; Bouzari, R.; Asemi, Z. The effects of acupuncture and electroacupuncture on Parkinson’s disease: Current status and future perspectives for molecular mechanisms. J. Cell. Biochem., 2019, 120(8), 12156-12166.
[http://dx.doi.org/10.1002/jcb.28654] [PMID: 30938859]

Puddu, A.; Mach, F.; Nencioni, A.; Viviani, G.L.; Montecucco, F. An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes. Mediators Inflamm., 2013, 2013, 1-9.
[http://dx.doi.org/10.1155/2013/591056] [PMID: 23365488]

Fernández-Millán. E.; Martín, M.A.; Goya, L.; Lizárraga-Mollinedo, E.; Escrivá, F.; Ramos, S.; Álvarez, C. Glucagon-like peptide-1 improves beta-cell antioxidant capacity via extracellular regulated kinases pathway and Nrf2 translocation. Free Radic. Biol. Med., 2016, 95, 16-26.
[http://dx.doi.org/10.1016/j.freeradbiomed.2016.03.002] [PMID: 26968794]

Matzinger, M.; Fischhuber, K.; Heiss, E.H. Activation of Nrf2 signaling by natural products-can it alleviate diabetes? Biotechnol. Adv., 2018, 36(6), 1738-1767.
[http://dx.doi.org/10.1016/j.biotechadv.2017.12.015] [PMID: 29289692]

Deng, C.; Cao, J.; Han, J.; Li, J.; Li, Z.; Shi, N.; He, J. Liraglutide activates the Nrf2/HO-1 antioxidant pathway and protects brain nerve cells against cerebral ischemia in diabetic rats. Comput. Intell. Neurosci., 2018, 2018, 1-7.
[http://dx.doi.org/10.1155/2018/3094504] [PMID: 29623090]

Kim, M.H.; Kim, E.H.; Jung, H.S.; Yang, D.; Park, E.Y.; Jun, H.S. EX4 stabilizes and activates Nrf2 via PKCδ contributing to the prevention of oxidative stress-induced pancreatic beta cell damage. Toxicol. Appl. Pharmacol., 2017, 315, 60-69.
[http://dx.doi.org/10.1016/j.taap.2016.12.005] [PMID: 27939242]

Maffei, A.; Lembo, G.; Carnevale, D. PI3 kinases in diabetes mellitus and its related complications. Int. J. Mol. Sci., 2018, 19(12), 4098.
[http://dx.doi.org/10.3390/ijms19124098] [PMID: 30567315]

Engelman, J.A.; Luo, J.; Cantley, L.C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet., 2006, 7(8), 606-619.
[http://dx.doi.org/10.1038/nrg1879] [PMID: 16847462]

Guan, G.; Zhang, J.; Liu, S.; Huang, W.; Gong, Y.; Gu, X. Glucagon-like peptide-1 attenuates endoplasmic reticulum stress–induced apoptosis in H9c2 cardiomyocytes during hypoxia/reoxygenation through the GLP-1R/PI3K/Akt pathways. Naunyn Schmiedebergs Arch. Pharmacol., 2019, 392(6), 715-722.
[http://dx.doi.org/10.1007/s00210-019-01625-2] [PMID: 30762075]

Jiang, Y.Q.; Chang, G.; Wang, Y.; Zhang, D.Y.; Cao, L.; Liu, J. Geniposide prevents hypoxia/reoxygenation-induced apoptosis in H9c2 cells: Improvement of mitochondrial dysfunction and activation of GLP-1R and the PI3K/AKT signaling pathway. Cell. Physiol. Biochem., 2016, 39(1), 407-421.
[http://dx.doi.org/10.1159/000445634] [PMID: 27372651]

Zhang, Y.; Zhou, H.; Wu, W.; Shi, C.; Hu, S.; Yin, T.; Ma, Q.; Han, T.; Zhang, Y.; Tian, F.; Chen, Y. Liraglutide protects cardiac microvascular endothelial cells against hypoxia/reoxygenation injury through the suppression of the SR-Ca2+–XO–ROS axis via activation of the GLP-1R/PI3K/Akt/survivin pathways. Free Radic. Biol. Med., 2016, 95, 278-292.
[http://dx.doi.org/10.1016/j.freeradbiomed.2016.03.035] [PMID: 27038735]

Kapodistria, K.; Tsilibary, E.P.; Kotsopoulou, E.; Moustardas, P.; Kitsiou, P. Liraglutide, a human glucagon‐like peptide‐1 analogue, stimulates AKT‐dependent survival signalling and inhibits pancreatic β‐cell apoptosis. J. Cell. Mol. Med., 2018, 22(6), 2970-2980.
[http://dx.doi.org/10.1111/jcmm.13259] [PMID: 29524296]

Hou, G.; Li, C.; Huan, Y.; Liu, S.; Liu, Q.; Liu, M.; Shen, Z. The PI3K/Akt1-FoxO1 translocation pathway mediates EXf effects on NIT-1 cell survival. Exp. Clin. Endocrinol. Diabetes, 2017, 125(10), 669-676.
[http://dx.doi.org/10.1055/s-0043-117048] [PMID: 28895639]

Kwon, D.Y.; Kim, Y.S.; Ahn, I.S.; Kim, D.S.; Kang, S.; Hong, S.M.; Park, S. Exendin-4 potentiates insulinotropic action partly via increasing β-cell proliferation and neogenesis and decreasing apoptosis in association with the attenuation of endoplasmic reticulum stress in islets of diabetic rats. J. Pharmacol. Sci., 2009, 111(4), 361-371.
[http://dx.doi.org/10.1254/jphs.09178FP] [PMID: 20019445]

Wang, C.; Chen, X.; Ding, X.; He, Y.; Gu, C.; Zhou, L. Exendin-4 promotes beta cell proliferation via PI3k/Akt signalling pathway. Cell. Physiol. Biochem., 2015, 35(6), 2233-2232.

Ballestri, S.; Zona, S.; Targher, G.; Romagnoli, D.; Baldelli, E.; Nascimbeni, F.; Roverato, A.; Guaraldi, G.; Lonardo, A. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J. Gastroenterol. Hepatol., 2016, 31(5), 936-944.
[http://dx.doi.org/10.1111/jgh.13264] [PMID: 26667191]

Yang, P.; Liang, Y.; Luo, Y.; Li, Z.; Wen, Y.; Shen, J.; Li, R.; Zheng, H.; Gu, H.F.; Xia, N. Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway. Diabetes Metab. Syndr. Obes., 2019, 12, 1013-1021.
[http://dx.doi.org/10.2147/DMSO.S206867] [PMID: 31308717]

Eizirik, D.L.; Cardozo, A.K.; Cnop, M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr. Rev., 2008, 29(1), 42-61.
[http://dx.doi.org/10.1210/er.2007-0015] [PMID: 18048764]

Alhusaini, S.; McGee, K.; Schisano, B.; Harte, A.; McTernan, P.; Kumar, S.; Tripathi, G. Lipopolysaccharide, high glucose and saturated fatty acids induce endoplasmic reticulum stress in cultured primary human adipocytes: Salicylate alleviates this stress. Biochem. Biophys. Res. Commun., 2010, 397(3), 472-478.
[http://dx.doi.org/10.1016/j.bbrc.2010.05.138] [PMID: 20515657]

van der Kallen, C.J.H.; van Greevenbroek, M.M.J.; Stehouwer, C.D.A.; Schalkwijk, C.G. Endoplasmic reticulum stress-induced apoptosis in the development of diabetes: Is there a role for adipose tissue and liver? Apoptosis, 2009, 14(12), 1424-1434.
[http://dx.doi.org/10.1007/s10495-009-0400-4] [PMID: 19757063]

Bakker, W.; Eringa, E.C.; Sipkema, P.; van Hinsbergh, V.W.M. Endothelial dysfunction and diabetes: Roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res., 2009, 335(1), 165-189.
[http://dx.doi.org/10.1007/s00441-008-0685-6] [PMID: 18941783]

Vilatoba, M.; Eckstein, C.; Bilbao, G.; Smyth, C.A.; Jenkins, S.; Thompson, J.A.; Eckhoff, D.E.; Contreras, J.L. Sodium 4-phenylbutyrate protects against liver ischemia reperfusion injury by inhibition of endoplasmic reticulum-stress mediated apoptosis. Surgery, 2005, 138(2), 342-351.
[http://dx.doi.org/10.1016/j.surg.2005.04.019] [PMID: 16153446]

Chen, J.; Xie, J.J.; Shi, K.S.; Gu, Y.T.; Wu, C.C.; Xuan, J.; Ren, Y.; Chen, L.; Wu, Y.S.; Zhang, X.L.; Xiao, J.; Wang, D.Z.; Wang, X.Y. Glucagon-like peptide-1 receptor regulates endoplasmic reticulum stress-induced apoptosis and the associated inflammatory response in chondrocytes and the progression of osteoarthritis in rat. Cell Death Dis., 2018, 9(2), 212.
[http://dx.doi.org/10.1038/s41419-017-0217-y] [PMID: 29434185]

Hardie, D.G.; Ross, F.A.; Hawley, S.A. AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol., 2012, 13(4), 251-262.
[http://dx.doi.org/10.1038/nrm3311] [PMID: 22436748]

Herzig, S.; Shaw, R.J. AMPK: Guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol., 2018, 19(2), 121-135.
[http://dx.doi.org/10.1038/nrm.2017.95] [PMID: 28974774]

Zhang, D.; Wang, W.; Sun, X.; Xu, D.; Wang, C.; Zhang, Q.; Wang, H.; Luo, W.; Chen, Y.; Chen, H.; Liu, Z. AMPK regulates autophagy by phosphorylating BECN1 at threonine 388. Autophagy, 2016, 12(9), 1447-1459.
[http://dx.doi.org/10.1080/15548627.2016.1185576] [PMID: 27304906]

Eid, A.A.; Ford, B.M.; Block, K.; Kasinath, B.S.; Gorin, Y.; Ghosh-Choudhury, G.; Barnes, J.L.; Abboud, H.E. AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes. J. Biol. Chem., 2010, 285(48), 37503-37512.
[http://dx.doi.org/10.1074/jbc.M110.136796] [PMID: 20861022]

Mangalam, A.K.; Rattan, R.; Suhail, H.; Singh, J.; Hoda, M.N.; Deshpande, M.; Fulzele, S.; Denic, A.; Shridhar, V.; Kumar, A.; Viollet, B.; Rodriguez, M.; Giri, S. AMP-activated protein kinase suppresses autoimmune central nervous system disease by regulating M1-type macrophage–Th17 axis. J. Immunol., 2016, 197(3), 747-760.
[http://dx.doi.org/10.4049/jimmunol.1501549] [PMID: 27354217]

Toyama, E.Q.; Herzig, S.; Courchet, J.; Lewis, T.L., Jr; Losón, O.C.; Hellberg, K.; Young, N.P.; Chen, H.; Polleux, F.; Chan, D.C.; Shaw, R.J. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress. Science, 2016, 351(6270), 275-281.
[http://dx.doi.org/10.1126/science.aab4138] [PMID: 26816379]

Ha, T.S.; Park, H.Y.; Nam, J.A.; Han, G.D. Diabetic conditions modulate the adenosine monophosphate-activated protein kinase of podocytes. Kidney Res. Clin. Pract., 2014, 33(1), 26-32.
[http://dx.doi.org/10.1016/j.krcp.2014.02.001] [PMID: 26877947]

Kamoshita, M.; Ozawa, Y.; Kubota, S.; Miyake, S.; Tsuda, C.; Nagai, N.; Yuki, K.; Shimmura, S.; Umezawa, K.; Tsubota, K. AMPK-NF-κB axis in the photoreceptor disorder during retinal inflammation. PLoS One, 2014, 9(7), e103013.
[http://dx.doi.org/10.1371/journal.pone.0103013] [PMID: 25048039]

Yerra, V.G.; Kalvala, A.K.; Sherkhane, B.; Areti, A.; Kumar, A. Adenosine monophosphate-activated protein kinase modulation by berberine attenuates mitochondrial deficits and redox imbalance in experimental diabetic neuropathy. Neuropharmacology, 2018, 131, 256-270.
[http://dx.doi.org/10.1016/j.neuropharm.2017.12.029] [PMID: 29273519]

Balteau, M.; Van Steenbergen, A.; Timmermans, A.D.; Dessy, C.; Behets-Wydemans, G.; Tajeddine, N.; Castanares-Zapatero, D.; Gilon, P.; Vanoverschelde, J.L.; Horman, S.; Hue, L.; Bertrand, L.; Beauloye, C. AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol., 2014, 307(8), H1120-H1133.
[http://dx.doi.org/10.1152/ajpheart.00210.2014] [PMID: 25128166]

Tang, S.T.; Su, H.; Zhang, Q.; Tang, H.Q.; Wang, C.J.; Zhou, Q.; Wei, W.; Zhu, H.Q.; Wang, Y. Sitagliptin inhibits endothelin-1 expression in the aortic endothelium of rats with streptozotocin-induced diabetes by suppressing the nuclear factor-κB/IκBα system through the activation of AMP-activated protein kinase. Int. J. Mol. Med., 2016, 37(6), 1558-1566.
[http://dx.doi.org/10.3892/ijmm.2016.2578] [PMID: 27122056]

Yang, Y.; Lu, Y.; Han, F.; Chang, Y.; Li, X.; Han, Z.; Xue, M.; Cheng, Y.; Sun, B.; Chen, L. Saxagliptin regulates M1/M2 macrophage polarization via CaMKKβ/AMPK pathway to attenuate NAFLD. Biochem. Biophys. Res. Commun., 2018, 503(3), 1618-1624.
[http://dx.doi.org/10.1016/j.bbrc.2018.07.090] [PMID: 30060948]

Mafi, A.; Yadegar, N.; Salami, M.; Salami, R.; Vakili, O.; Aghadavod, E. Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy. Pathol. Res. Pract., 2021, 227, 153618.
[http://dx.doi.org/10.1016/j.prp.2021.153618] [PMID: 34649056]

Biolo, A.; Ramamurthy, S.; Connors, L.H.; O’Hara, C.J.; Meier-Ewert, H.K.; Soo Hoo, P.T.; Sawyer, D.B.; Seldin, D.S.; Sam, F. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: Relationship to structural, functional myocardial changes and to light chain amyloid deposition. Circ. Heart Fail., 2008, 1(4), 249-257.
[http://dx.doi.org/10.1161/CIRCHEARTFAILURE.108.788687] [PMID: 19808299]

Xu, W.W.; Guan, M.P.; Zheng, Z.J.; Gao, F.; Zeng, Y.M.; Qin, Y.; Xue, Y.M. Exendin-4 alleviates high glucose-induced rat mesangial cell dysfunction through the AMPK pathway. Cell. Physiol. Biochem., 2014, 33(2), 423-432.
[http://dx.doi.org/10.1159/000358623] [PMID: 24556697]

Zeng, Y.; Li, C.; Guan, M.; Zheng, Z.; Li, J.; Xu, W.; Wang, L.; He, F.; Xue, Y. The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms. Cardiovasc. Diabetol., 2014, 13(1), 32.
[http://dx.doi.org/10.1186/1475-2840-13-32] [PMID: 24490809]

Bouchi, R.; Nakano, Y.; Fukuda, T.; Takeuchi, T.; Murakami, M.; Minami, I.; Izumiyama, H.; Hashimoto, K.; Yoshimoto, T.; Ogawa, Y. Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: A randomized control trial. Endocr. J., 2016, EJ16-EJ0449.
[PMID: 27916783]

Gerstein, H.C.; Colhoun, H.M.; Dagenais, G.R.; Diaz, R.; Lakshmanan, M.; Pais, P.; Probstfield, J.; Botros, F.T.; Riddle, M.C.; Rydén, L.; Xavier, D.; Atisso, C.M.; Dyal, L.; Hall, S.; Rao-Melacini, P.; Wong, G.; Avezum, A.; Basile, J.; Chung, N.; Conget, I.; Cushman, W.C.; Franek, E.; Hancu, N.; Hanefeld, M.; Holt, S.; Jansky, P.; Keltai, M.; Lanas, F.; Leiter, L.A.; Lopez-Jaramillo, P.; Cardona Munoz, E.G.; Pirags, V.; Pogosova, N.; Raubenheimer, P.J.; Shaw, J.E.; Sheu, W.H.H.; Temelkova-Kurktschiev, T.; Abella, M.; Alebuena, A.; Almagro, S.; Amoroso, E.; Anadon, P.; Andreu, E.; Aristimuño, G.; Arzadun, M.; Barbieri, M.; Barcudi, R.; Bartolacci, I.; Bolobanich, G.; Bordonava, A.; Bustamante Labarta, M.; Bustos, B.; Caccavo, A.; Camino, A.; Cantero, M.; Carignano, M.; Cartasegna, L.; Cipullo, M.; Commendatore, V.; Conosciuto, V.; Costamagna, O.; Crespo, C.; Cuello, J.; Cuneo, C.; Cusimano, S.; Dean, S.; Dituro, C.; Dominguez, A.; Farah, M.; Fernandez, A.; Fernandez, F.; Ferrari, A.; Flammia, P.; Fuentealba, J.; Gallardo, K.B.; Garcia, C.; Garcia Duran, R.; Garrido, M.; Gavicola, R.; Gerbaudo, C.; Gilli, G.; Giotto, A.P.; Godoy Bolzán, P.; Gomez Vilamajo, O.; Guerlloy, F.; Guridi, C.; Gutierrez Garrido, N.; Hasbani, E.; Hermida, S.; Hominal, M.; Hrabar, A.; Ingaramo, A.; Izzicupo, A.; Krynski, M.; Lagrutta, M.; Lanchiotti, P.; Langhe, M.; Leonard, V.; Llanos, J.; Lopez Santi, R.; Lowenstein, J.; Luquez, C.; Mackinnon, I.; Mana, M.; Manzur, S.; Marino, J.; Martella, C.; Martinez, R.; Matias, R.; Matkovich, J.; Meritano, M.; Montaña, O.; Mulazzi, M.; Ochoa, J.; Paterlini, G.; Pelagagge, M.; Peralta Lopez, M.E.; Prado, A.; Pruyas, L.; Racca, M.; Ricotti, C.; Rodriguez, C.; Romero Vidomlansky, M.; Ronderos, R.; Sadowski, A.L.; Sala, J.; Sánchez, A.; Santoro, A.; Schiavi, L.; Sein, M.; Sernia, V.; Serra, L.; Sicer, M.; Smith, T.; Soso, L.; Sposetti, G.; Steinacher, A.; Stival, J.; Tedesco, J.; Tonin, H.; Tortolo, M.; Ulla, M.; Vallejos, J.; Vico, M.; Virgillito, L.; Visco, V.; Vogel, D.; Waisman, F.; Zaidman, C.; Zucchiatti, N.; Badshah, I.; Cohen, N.; Colman, P.; Colquhoun, D.; Davis, T.; Fourlanos, S.; Fulcher, G.; Hamlyn, J.; Haywood, C.; Hocking, S.; Huchinson, M.; Jeffries, W.; Kyl, M.; Lo, C.; Mah, P.M.; Makepeace, A.; Marope, D.; Nanayakkar, N.; Nankervis, A.; Palmer, N.; Palolus, B.; Pillai, S.; Price, S.; Price, S.; Proietto, J.; Reutens, A.; Rodrigo, N.; Sheikh, A.; Smith, G.; So, M.; Soldatos, G.; Stuckey, B.; Sumithran, P.; Teede, H.; Vora, P.; Williams, L.; Abib, E.; Adão Poço, C.; Alves, É.F.; Andreatta Bernardi Barea, J.; Avezum Oliveira, L.; Castro, D.L.C.; Correa da Cruz, I.; Costa, M.; Cruz, I.; Cunha, S.; Da Silva, M.A.V.; de Carvalho Camara Bona, R.; de Paula, B.; Eliaschewitz, F.; Fazolli, G.; Ferreira Filho, C.A.; Fortes, J.; França, C.; Franco, D.R.; Genestreti, P.R.; Giorgeto, F.; Gonçalves, R.M.; Grossman, M.E.; Henrique Marcelino, A.C.; Hernandes, M.; Horta, A.; Jaeger, C.; Kaneblai, M.; Kauffman Rutenberg, C.; Kerr Saraiva, J.F.; Lemos, M.A.; Maia, L.; Manenti, E.R.; Marques, M.; Melissa Valerio, C.; Moreira, R.; Mothé, F.; Mouco, O.M.; Moura, P.; Moura Jorge, J.C.; Nakashima, C.; Nakazone, M.; Napoli, T.; Nunes, C.; Nunes Salles, J.E.; Oliveira, K.; Oliveira, M.; Pantano, G.S.; Petri, F.; Piazza, L.; Pires, A.C.; Pizzato, P.; Prata, S.; Precoma, D.; Rech, R.; Reis, G.; Reis, H.; Resende, E.; Ribas Fortes, J.; Rodovalho, S.; Rossi dos Santos, F.; Salles, J.E.; Sampaio, C.R.; Santos, T.; Santos dos Santos, V.; Silva e Quadros, T.; Silveira, D.; Siqueira, K.N.; Teireira, M.; Uehara, M.; Valerio, C.; Vianna, H.; Vidotti, M.H.; Visconti, G.L.; Zanella, M.T.; Andreeva, V.; Borisov, R.; Botushanov, N.; Dimitrov, G.; Dimova, K.; Dragoychev, T.; Grigorova, V.; Gushterova, V.; Ivanov, I.; Kocelova, T.; Kurktschiev, D.; Miletieva, M.; Nenkova-Gugusheva, N.; Pancheva, R.; Pavlova, M.; Raev, D.; Spasova, V.; Stoikov, A.; Troev, D.; Yanev, T.; Yoncheva-Mihaylova, M.; Abitbol, A.; Ajala, B.; Alguwaihes, A.; Ardilouze, J-L.; Aris-Jilwan, N.; Arnaout, A.; Aronson, R.; Aslam, N.; Babin, S.; Bailargeon, J-P.; Bailey, A.; Bajaj, H.; Beauchesne, C.; Beca, S.; Belanger, A.; Bell, A.; Bellabarba, D.; Berard, L.; Berenbaum, B.; Bergeron, V.; Berlingieri, J.; Bernier, F.; Bishara, P.; Blank, D.; Blumer, I.; Brault, S.; Breton, D.; Carpentier, A.; Cha, J.; Chandra, P.; Chiasson, J-L.; Conway, J.R.; Couture, G.; Couture, N.; Dagenais, G.; Datta, D.; D’Ignazio, G.; Dumas, R.; Fay, D.; Frechette, A.; Frenette, L.; Fung, D.; Gagnon, N.; Galter, M.; Garon, J.; Gauthier, J.S.; Geadah, C.; Gilbert, J.; Girard, R.; Goldenberg, R.; Grossman, L.D.; Gupta, N.; Halle, J-P.; Hivert, M-F.; Houde, G.; Houlden, R.; Hramiak, I.; Jablonski, T.; Jain, A.J.; Khandwala, H.; Khosla, M.; Lachance, C.; Laflamme, E.; Langlois, M-F.; Larivee, L.; Liutkus, J.; Lochnan, H.; Malik, S.; McDonald, C.; Mehta, P.; Mihailidis, J.; Milot, A.; Narula, P.; Nault, P.; Nayar, A.; Nisker, W.; Ouellet, G.; Palardy, J.; Patel, M.; Paul, T.; Pedersen, S.; Perron, P.; Pesant, M-H.; Poirier, P.; Poulin, M-C.; Punthakee, Z.; Rehman, W.; Ross, S.; Sagar, P.; Saliba, N.; Sandler, S.; Schiffrin, A.; Schlosser, R.; Seth-Sharma, A.; Sherman, M.; Sionit, D.; Sivakumar, T.; Soto, J.; St-Amour, E.; Steen, O.; Sussman, J.; Telner, A.; Tobe, S.; Twum-Barima, D-Y.; Van Zanten, A.; VanRossum, N.; Vecchiarelli, J.; Ward, R.; Wessengel, J.; Weisnagel, S.; Wilderman, I.; Woo, V.; Yakubovich, N.; Yale, J-F.; Yared, Z.; Acevedo, M.; Aguirre, M.L.; Aizman, A.; Barroso, M.S.; Cobos, L.; Danin Vargas, A.; Descalzi, B.; Godoy, G.; Grumberg, E.; Lahsen, R.; Larenas, G.; Ortiz, E.; Paredes, J.; Potthoff, S.; Retamal, E.; Rojas, L.; Salgado, M.; Santibanez, C.; Solis, C.; Stokins, B.; Accini, J.; Acebedo, J.; Agudelo Baena, L.M.; Alarcon, S.; Angel, J.; Arcos, E.; Aroca Martinez, M.; Atuesta, L.; Balaguera, J.; Ballestas, D.; Barrera, S.I.; Barrios Reyes, R.; Bayona, A.; Bermudez, A.; Bernal, D.Z.; Blanquicett, M.; Bravo, V.; Bueno, W.; Burbano Delgado, A.; Cadena, A.; Cadena, A.; Caicedo, S.; Celemin, C.; Consuegra, R.; Contreras Pimienta, C.; Corredor, K.J.; Cure, C.; De La Hoz Rueda, L.D.; Delgado, E.; Diaz, S.; Diego, M.; Donado, A.; Encinales Sanabria, W.; Escobar, J.; Escorcia, G.; Forero, L.; Fuentes, L.; Garcia, M.; Garcia Lozada, H.; Garcia Ortiz, L.; Giraldo, A.; Gomez Gonzalez, L.; Granada, J.; Gutierrez, C.; Henao, N.; Hernandez, E.; Herrera Uejbe, O.M.; Higuera Cobos, J.D.; Ibarra Gómez, J.; Jaimes, E.H.; Jaramillo, M.; Jaramillo, N.; Jaramillo Gomez, C.; Jaramillo Sanchez, M.; Jarava Durán, I.; Lopez Ceballos, C.; Madrid, C.; María Amastha, E.; Mercado, J.; Molina, D.I.; Molina Soto, J.; Montoya, C.; Morales, A.; Muñoz, C.; Orozco, L.A.; Osorio, O.; Palmera Sanchez, J.M.; Peña, A.; Perez, J.; Perez Agudelo, J.; Pérez Amador, G.; Pertuz, C.; Posada, I.; Puerta, C.; Quintero, A.; Quiroz, D.; Rendon, C.; Reyes, A.; Reyes, A.; Ripoll, D.; Rivera, C.; Rocha, M.; Rodriguez, J.F.; Rodriguez Villanueva, K.A.; Rodriguez Zabala, J.E.; Rojas, S.; Romero, M.; Rosero, R.; Rosillo Cardenas, A.R.; Rueda, L.; Sanchez, G.; Sanchez, T.; Sotomayor Herazo, A.; Suarez, M.; Torres, M.; Trujillo, F.; Urina, M.; Van Strahlen, L.; Velandia, C.; Velasquez Guzman, C.; Velazquez, E.; Vidal Prada, T.; Yepez Alvaran, J.P.; Zarate, D.; Andelova, J.; Benesova, R.; Buzova, B.; Cech, V.; Chodova, I.; Choura, M.; Dufka, A.; Gamova, A.; Gorgol, J.; Hala, T.; Havlova, H.; Hlavkova, D.; Horanska, P.; Ilcisin-Valova, J.; Jenickova, P.; Jerabek, O.; Kantorova, I.; Kolomaznikova, K.; Kopeckova, I.; Kopeckova, M.; Linhart, K.; Linhart, T.; Malecha, J.; Malicherova, E.; Neubauerova, D.; Oznerova, M.; Partys, R.; Pederzoliova, E.; Petrusova, M.; Prymkova, V.; Racicka, E.; Reissova, I.; Roderova, E.; Stanek, L.; Striova, A.; Svarcova, D.; Svoboda, P.; Szeghy Malicharova, E.; Urge, J.; Vesely, L.; Wasserburger, B.; Wasserburgerova, H.; Zahumensky, E.; Zamrazil, V.; Alawi, H.; Anastasiadis, E.; Axthelm, E.; Bieler, T.; Buhrig, C.; Degtyareva, E.; Dellanna, F.; Derwahl, K-M.; Diessel, S.; Dogiami, B.; Dorn-Weitzel, K.; Ernst, M.; Faulmann, G.; Fetscher, B.; Forst, T.; Freyer-Lahres, G.; Funke, K.; Ganz, X.; Gleixner, C.; Hanefeld, C.; Heinrichs, S.; Helleberg, S.; Henkel, E.; Hetzel, G.R.; Hoffmann, C.; Jacob, F.; Jacob, S.; John, F.; Jonczyk, A.; Kamke, W.; Klein, C.; Kleinhardt, M.; Kleophas, W.; Kosch, C.; Kreutzmann, K.; Kühn, A.; Lee-Barkey, Y.H.; Lier, A.; Maatouk, S.; Minnich, J.; Mitry, M.; Muessig, I.; Nicula, D.; Niemann, M.; Nothroff, J.; Ott, P.; Pfuetzner, A.; Pfützner, A.; Pistrosch, F.; Pohl, W.; Prochazkova, Z.; Retkowska, M.; Rosin, H.; Sachsenheimer, D.; Samer, H.; Sanuri, M.; Schaefer, A.; Schaper, F.; Schulze, E-D.; Schulze, M.; Schumann, M.; Segiet, T.; Sowa, V.; Stahl, H-D.; Steinfeldt, F.; Teige, M.; Trieb, B.; Tschoepe, D.; Uebel, P.; Warken, B.; Weigmann, I.; Weyland, K.; Wilhelm, K.; Balo, T.; Balsay, M.; Bende, I.; Bezzegh, K.; Birkus, Z.; Buday, B.; Csomai, M.; Deak, L.; Dezso, E.; Faludi, P.; Faluvegi, M.; Fazekas, I.; Feher, A.; Fejer, C.; Finta, E.; Fulcz, A.; Gaal, Z.; Gurzo, M.; Hati, K.; Herczeg, G.; Jozsef, I.; Juhasz, M.; Keltai, K.; Koranyi, L.; Kulcsar, E.; Kun, K.; Laczko, A.; Literáti-Nagy, B.; Mezo, I.; Mileder, M.; Moricz, I.; Nagy, K.; Nagybaczoni, B.; Nemeth, C.; Oze, A.; Pauer, J.; Peterfai, E.; Polocsanyi, B.; Poor, F.; Reiber, I.; Salamon, C.; Sebestyen, J.; Torok, I.; Tuu, M.; Varga, A.; Vass, V.; Ahn, C.M.; Ahn, C.; ByungWon, P.; Chang, H-J.; Chang, K.; Choi, E-Y.; Choi, H.S.; Chung, J-W.; Hong, B-K.; Hong, Y.J.; Hyon, M.S.; Jeong, M.H.; Kang, S.; Kim, B-K.; Kim, J-H.; Kim, J.H.; Kim, K-S.; Kim, K-S.; Kim, M.H.; Kim, P-J.; Kim, S-K.; Kim, Y-S.; Kim, Y.K.; Koh, Y.S.; Kwon, H.M.; Lee, B.K.; Lee, B-W.; Lee, J.B.; Lee, M-M.; Lim, Y-M.; Min, P.K.; Park, J.S.; Park, J.; Park, K.H.; Park, S.; Pyun, W.B.; Rim, S.J.; Ryu, D-R.; Seo, H-S.; Seung, K.B.; Shin, D-H.; Sim, D.S.; Yoon, Y.W.; Andersone, I.; Babicka, K.; Balcere, I.; Barons, R.; Capkovska, I.; Geldnere, K.; Grigane, I.; Jegere, B.; Lagzdina, I.; Mora, L.; Pastare, S.; Ritenberga, R.; Romanova, J.; Saknite, I.; Sidlovska, N.; Sokolova, J.; Steina, S.; Strizko, I.; Teterovska, D.; Vizina, B.; Barsiene, L.; Belozariene, G.; Daugintyte-Petrusiene, L.; Drungiliene, N.; Garsviene, N.; Grigiene, A.; Grizas, V.; Jociene, V.; Kalvaitiene, D.; Kaupiene, J.; Kavaliauskiene, J.; Kozloviene, D.; Lapteva, I.; Maneikiene, B.; Marcinkeviciene, J.; Markauskiene, V.; Meiluniene, S.; Norkus, A.; Norviliene, R.; Petrenko, V.; Radzeviciene, R.; Sakalyte, G.; Urbonas, G.; Urbutiene, S.; Vasiliauskas, D.; Velickiene, D.; Aguilar, C.; Alcocer, M.; Avalos-Ramirez, J.A.; Banda-Elizondo, R.; Bricio-Ramirez, R.; Cardenas Mejia, K.; Cavazos, F.; Chapa, J.; Cienfuegos, E.; De la Peña, A.; de la Peña Topete, G.; De los Rios Ibarra, M.O.; Elias, D.; Flores-Moreno, C.; Garcia Hernandez, P.; Gonzalez, L.G.; Guerra Moya, R.L.; Guerra-Lopez, A.; Hernandez Baylon, R.; Herrera Colorado, C.; Herrera-Marmolejo, M.; Islas-Palacios, N.; Lopez, E.; Lopez, F.; Lopez Alvarado, A.; Luna Ceballos, R.I.; Morales Villegas, E.; Moreno-Virgen, G.; Parra Perez, R.L.; Pascoe Gonzalez, S.; Peralta-Cantu, I.; Previn, R.; Ramirez, R.; Ramirez, R.; Ramos Zavala, M.G.; Rodriguez, M.; Salgado-Sedano, R.; Sanchez-Aguilar, A.C.; Santa Rosa Franco, E.; Sauque-Reyna, L.; Suarez Otero, R.; Torres, I.; Velarde-Harnandez, E.; Villagordoa, J.; Villeda-Espinoza, E.; Vital-Lopez, J.; Zavala- Bello, C.J.; Baker, J.; Barrington-Ward, E.; Brownless, T.; Carroll, R.; Carson, S.; Choe, M.; Corin, A.; Corley, B.; Cutfield, R.; Dalaman, N.; Dixon, P.; Drury, P.; Dyson, K.; Florkowski, C.; Ford, M.; Frengley, W.; Helm, C.; Katzen, C.; Kerr, J.; Khanolkar, M.; Kim, D.; Koops, R.; Krebs, J.; Leikis, R.; Low, K.; Luckey, A.; Luke, R.; Macaulay, S.; Marks, R.; McNamara, C.; Millar-Coote, D.; Miller, S.; Mottershead, N.; Reid, J.; Robertson, N.; Rosen, I.; Rowe, D.; Schmiedel, O.; Scott, R.; Sebastian, J.; Sheahan, D.; Stiebel, V.; Ternouth, I.; Tofield, C.; Venter, D.; Williams, M.; Williams, M.; Wu, F.; Young, S.; Arciszewska, M.; Bochenek, A.; Borkowski, P.; Borowy, P.; Chrzanowski, T.; Czerwinski, E.; Dwojak, M.; Grodzicka, A.; Janiec, I.; Jaruga, J.; Jazwinska-Tarnawska, E.K.; Jedynasty, K.; Juzwiak-Czapiewska, D.; Karczewicz-Janowska, J.; Konieczny, J.; Konieczny, M.; Korol, M.; Kozina, M.; Krzyzagorska, E.; Kucharczyk-Petryka, E.; Laz, R.; Majchrzak, A.; Mrozowska, Z.; Mularczyk, M.; Nowacka, E.; Peczynska, J.; Petryka, R.; Pietrzak, R.; Pisarczyk-Wiza, D.; Rozanska, A.; Ruzga, Z.; Rzeszotarska, E.; Sacha, M.; Sekulska, M.; Sidorowicz-Bialynicka, A.; Stasinska, T.; Strzelecka-Sosik, A.; Swierszcz, T.; Szymkowiak, K.M.; Turowska, O.; Wisniewska, K.; Wiza, M.; Wozniak, I.; Zelazowska, K.; Ziolkowska-Gawron, B.; Zytkiewicz-Jaruga, D.; Albota, A.; Alexandru, C.; Avram, R.; Bala, C.; Barbonta, D.; Barbu, R.; Braicu, D.; Calutiu, N.; Catrinoiu, D.; Cerghizan, A.; Ciorba, A.; Craciun, A.; Doros, R.; Duma, L.; Dumitrache, A.; Ferariu, I.; Ferician Moza, A.; Ghergan, A.; Ghise, G.; Graur, M.; Gribovschi, M.; Mihai, B.; Mihalache, L.; Mihalcea, M.; Mindrescu, N.; Morosanu, M.; Morosoanu, A.; Mota, M.; Moza, A.; Nafornita, V.; Natea, N.; Nicodim, S.; Nita, C.; Onaca, A.; Onaca, M.; Pop, C.; Pop, L.; Popa, A.; Popescu, A.; Pruna, L.; Roman, G.; Rosu, M.; Sima, A.; Sipciu, D.; Sitterli-Natea, C.N.; Szilagyi, I.; Tapurica, M.; Tase, A.; Tutescu, A-C.; Vanghelie, L.; Verde, I.; Vlad, A.; Zarnescu, M.; Akhmetov, R.; Allenova, I.; Avdeeva, I.; Baturina, O.; Biserova, I.; Bokovin, N.; Bondar, I.; Burova, N.; Chufeneva, G.; Chumachek, E.; Demidova, M.; Demin, A.; Drobysheva, V.; Egorova, I.; Esenyan, L.; Gelig, E.; Gilyarevsky, S.; Golshmid, M.; Goncharov, A.; Gorbunova, A.; Gordeev, I.; Gorelysheva, V.; Goryunova, T.; Grebenshchikova, I.; Ilchenko, R.; Ivannikova, M.; Karabalieva, S.; Karpeeva, J.; Khaykina, E.; Kobalava, Z.; Kononenko, I.; Korolik, O.; Korshunova, A.; Kostenko, V.; Krasnopevtseva, I.; Krylova, L.; Kulkova, P.; Kuzmina, I.; Ledyaeva, A.; Levashov, S.; Lokhovinina, N.; Lvov, V.; Martirosyan, N.; Nedogoda, S.; Nilk, R.; Osmolovskaya, Y.; Panov, A.; Paramonova, O.; Pavlova, E.; Pekareva, E.; Petunina, N.; Ponamareva, S.; Reshedko, G.; Salasyuk, A.; Sepkhanyan, M.; Serebrov, A.; Shabelnikova, O.; Skvortsov, A.; Smirnova, O.; Spiridonova, O.; Strogova, S.; Taratukhin, E.; Tereschenko, S.; Trukhina, L.; Tsarkova, O.; Tsoma, V.; Tumarov, F.; Tyan, N.; Tyurina, T.; Villevalde, S.; Yankovaya, E.; Zarutskaya, L.; Zenkova, E.; Badat, A.; Bester, F.; Blignaut, S.; Blom, D.; Booysen, S.; Boyd, W.; Brice, B.; Brown, S.; Burgess, L.; Cawood, R.; Coetzee, K.; Conradie, H.; Cronje, T.; de Jong, D.; Ellis, G.; Emanuel, S.; Engelbrecht, I.; Foulkes, S.; Fourie, D.; Gibson, G.; Govender, T.; Hansa, S.; Hemus, A.C.; Hendricks, F.; Heradien, M.; Holmgren, C.; Hoosain, Z.; Horak, E.; Howard, J.; Immink, I.; Janari, E.; Jivan, D.; Klusmann, K.; Labuschagne, W.; Lai, Y.; Latiff, G.; Lombaard, J.; Lottering, H.; Meeding, R.; Middlemost, S.; Mitha, H.; Mitha, I.; Mkhwanazi, S.; Moodley, R.; Murray, A.; Musungaie, D.; Osman, Y.; Peacey, K.; Pillay-Ramaya, L.; Pretorius, C.; Prozesky, H.; Sarvan, M.; Scholtz, E.; Sebesteny, A.; Skinner, B.; Skriker, M.; Smit, M.; Stapelberg, A-M.; Swanepoel, N.; Urbach, D.; van Aswegen, D.; van Zyl, F.; Van Zyl, L.; Venter, E.; Wadvalla, S.; Wing, J.; Wolmarans, K.; Abreu, C.; Aguilà, P.; Aguilera, E.; Alonso, N.; Alvarez, C.; Cajas, P.; Castro, J.C.; Codinachs, R.; Contreras, J.; Coves, M.J.; Fajardo, C.; Ferrer, J.C.; Font, N.; Garcia, M.; Gil, M.A.; Gomez, F.; Gomez, L.A.; Gonzalbez, J.; Griera, J.L.; Masmiquel, L.; Mauricio, D.; Narejos Perez, S.; Nicolau, J.A.; Noheda Contreras, O.; Olivan, J.; Olivares, J.; Ortega, E.; Pellitero, S.; Pertusa, S.; Rius, F.; Rodriguez, I.; Sánchez-Juan, C.; Santos, D.; Soldevila, B.; Subias, D.; Terns, M.; Trescoli, C.; Vilaplana, J.; Villanueva, A.; Albo, J.; Antus, K.; Axelsson, M.; Bergström, L.; Binsell-Gerdin, E.; Boman, K.; Botond, F.; Dotevall, A.; Graipe, A.; Jarnet, C.; Kaminska, J.; Kempe, A.; Korhonen, M.; Linderfalk, C.; Liu, B.; Ljungstroem, K.; Ljungström, K.; Malmqvist, L.; Mellbin, L.; Mooe, T.; Nicol, P.; Norrby, A.; Ohlsson, A.; Rosengren, A.; Saaf, J.; Salmonsson, S.; Strandberg, O.; Svensson, K-A.; Tengmark, B-O.; Tsatsaris, G.; Ulvenstam, A.; Vasko, P.; Chang, C-T.; Chang, H-M.; Chen, J-F.; Chen, T-P.; Chung, M-M.; Fu, C-P.; Hsia, T-L.; Hua, S-C.; Kuo, M-C.; Lee, C.; Lee, I-T.; Liang, K-W.; Lin, S.Y.; Lu, C-H.; Ma, W-Y.; Pei, D.; Shen, F-C.; Su, C-C.; Su, S-W.; Tai, T-S.; Tsai, W-N.; Tsai, Y-T.; Tung, S-C.; Wang, J-S.; Yu, H-I.; Al-Qaissi, A.; Arutchelvam, V.; Atkin, S.; Au, S.; Aye, M.M.; Bain, S.; Bejnariu, C.; Bell, P.; Bhatnagar, D.; Bilous, R.; Black, N.; Brennan, U.; Brett, B.; Bujanova, J.; Chow, E.; Collier, A.; Combe, A.; Courtney, C.; Courtney, H.; Crothers, J.; Eavis, P.; Elliott, J.; Febbraro, S.; Finlayson, J.; Gandhi, R.; Gillings, S.; Hamling, J.; Harper, R.; Harris, T.; Hassan, K.; Heller, S.; Jane, A.; Javed, Z.; Johnson, T.; Jones, S.; Kennedy, A.; Kerr, D.; Kilgallon, B.; Konya, J.; Lindsay, J.; Lomova-Williams, L.; Looker, H.; MacFarlane, D.; Macrury, S.; Malik, I.; McCrimmon, R.; McKeith, D.; McKnight, J.; Mishra, B.; Mukhtar, R.; Mulligan, C.; O’Kane, M.; Olateju, T.; Orpen, I.; Richardson, T.; Rooney, D.; Ross, S.B.; Sathyapalan, T.; Siddaramaiah, N.; Sit, L.E.; Stephens, J.; Turtle, F.; Wakil, A.; Walkinshaw, E.; Ali, A.; Anderson, R.; Arakaki, R.; Aref, O.; Ariani, M.K.; Arkin, D.; Banarer, S.; Barchini, G.; Bhan, A.; Branch, K.; Brautigam, D.; Brietzke, S.; Brinas, M.; Brito, Y.; Carter, C.; Casagni, K.; Casula, S.; Chakko, S.; Charatz, S.; Childress, D.; Chow, L.; Chustecka, M.; Clarke, S.; Cohen, L.; Collins, B.; Colon Vega, G.; Comulada-Rivera, A.; Cortes-Maisonet, G.; Davis, M.; de Souza, J.; Desouza, C.; Dinnan, M.; Duffy-Hidalgo, B.; Dunn, B.; Dunn, J.; Elman, M.; Felicetta, J.; Finkelstein, S.; Fitz-Patrick, D.; Florez, H.; Forker, A.; Fowler, W.; Fredrickson, S.; Freedman, Z.; Gainey Narron, B.; Gainey-Ferree, K.; Gardner, M.; Gastelum, C.; Giddings, S.; Gillespie, E.; Gimness, M.P.; Goldstein, G.; Gomes, M.; Gomez, N.; Gorman, T.; Goswami, K.; Graves, A.; Hacking, S.; Hall, C.; Hanson, L.; Harman, S.; Heber, D.; Henry, R.; Hiner, J.; Hirsch, I.; Hollander, P.; Hooker, T.; Horowitz, B.; Hoste, L.; Huang, L.; Huynh, M.; Hyman, D.; Idriss, S.; Iranmanesh, A.; Karounos, D.; Kashyap, M.; Katz, L.; Kaye, W.; Khaiton, Y.; Khardori, R.; Kitchen, T.; Klein, A.; Knffem, W.; Kosiborod, M.; Kreglinger, N.; Kruger, D.; Kumar, A.; Laboy, I.; Larrabee, P.; Larrick, L.; Lawson, D.; Ledet, M.; Lenhard, J.; Levy, J.; Li, G.; Li, Z.; Lieb, D.; Limcolioc, A.; Lions-Patterson, J.; Lorber, D.; Lorch, D.; Lorrello, M.; Lu, P.; Lucas, K.J.; Ma, S-L.; MacAdams, M.; Magee, M.; Magno, A.; Mahakala, A.R.; Marks, J.; McCall, A.; McClanahan, W., Jr; McClary, C.; Melendez, L.; Melish, J.; Michaud, D.; Miller, C.; Miller, N.; Mora, P.; Moten, M.; Mudaliar, S.; Myrick, G.; Narayan, P.; Nassif, M.; Neri, K.; Newton, T.; Niblack, P.; Nicol, P.; Nyenwe, E.; Odugbesan, A.O.; Okorocha, Y.; Ortiz Carrasquillo, R.; Osei, K.; Palermo, C.; Patel, H.; Patel, K.; Pau, C.; Perley, M.; Plevin, S.; Plummer, E.; Powell, R.; Qintar, M.; Rawls, R.; Reyes-Castano, J.; Reynolds, L.; Richards, R.; Rosenstock, J.; Rowe, C.; Saleh, J.; Sam, S.; Sanchez, A.; Sander, D.; Sanderson, B.; Savin, V.; Seaquist, E.; Shah, J.; Shi, S.; Shivaswamy, V.; Shlotzhauer, T.; Shore, D.; Skukowski, B.; Soe, K.; Solheim, V.; Soufer, J.; Steinberg, H.; Steinsapir, J.; Tarkington, P.; Thayer, D.; Thomson, S.; Thrasher, J.; Tibaldi, J.; Tjaden, J.; Tores, O.; Trence, D.; Trikudanathan, S.; Ullal, J.; Uwaifo, G.; Vo, A.; Vu, K.; Walia, D.; Weiland, K.; Whitehouse, F.; Wiegmann, T.; Wyne, K.; Wynne, A.; Yuen, K.; Zaretzky, J.; Zebrack, J.; Zieve, F.; Zigrang, W. Dulaglutide and renal outcomes in type 2 diabetes: An exploratory analysis of the REWIND randomised, placebo-controlled trial. Lancet, 2019, 394(10193), 131-138.
[http://dx.doi.org/10.1016/S0140-6736(19)31150-X] [PMID: 31189509]

Awal, H.B.; Nandula, S.R.; Domingues, C.C.; Dore, F.J.; Kundu, N.; Brichacek, B.; Fakhri, M.; Elzarki, A.; Ahmadi, N.; Safai, S.; Fosso, M.; Amdur, R.L.; Sen, S. Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: A randomized controlled trial. Cardiovasc. Diabetol., 2020, 19(1), 72.
[http://dx.doi.org/10.1186/s12933-020-01046-z] [PMID: 32493344]

Liu, X.; Huang, J.; Li, J.; Mao, Q.; He, J. Effects of liraglutide combined with insulin on oxidative stress and serum MCP-1 and NF-kB levels in Type 2 diabetes. J. Coll. Physicians Surg. Pak., 2019, 29(3), 218-221.
[http://dx.doi.org/10.29271/jcpsp.2019.03.218] [PMID: 30823945]

Ott, C.; Raff, U.; Schmidt, S.; Kistner, I.; Friedrich, S.; Bramlage, P.; Harazny, J.M.; Schmieder, R.E. Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes. Cardiovasc. Diabetol., 2014, 13(1), 19.
[http://dx.doi.org/10.1186/1475-2840-13-19] [PMID: 24423149]

Johansen, N.J.; Dejgaard, T.F.; Lund, A.; Schlüntz, C.; Frandsen, C.S.; Forman, J.L.; Wewer Albrechtsen, N.J.; Holst, J.J.; Pedersen-Bjergaard, U.; Madsbad, S.; Vilsbøll, T.; Andersen, H.U.; Knop, F.K. Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): A randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol., 2020, 8(4), 313-324.
[http://dx.doi.org/10.1016/S2213-8587(20)30030-9] [PMID: 32135138]

Tanimura-Inagaki, K.; Nagao, M.; Harada, T.; Sugihara, H.; Moritani, S.; Sasaki, J.; Kono, S.; Oikawa, S. Sitagliptin improves plasma apolipoprotein profile in type 2 diabetes: A randomized clinical trial of sitagliptin effect on lipid and glucose metabolism (SLIM) study. Diabetes Res. Clin. Pract., 2020, 162, 108119.
[http://dx.doi.org/10.1016/j.diabres.2020.108119] [PMID: 32194219]

Jaiswal, M.; Martin, C.L.; Brown, M.B.; Callaghan, B.; Albers, J.W.; Feldman, E.L.; Pop-Busui, R. Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study. J. Diabetes Complications, 2015, 29(8), 1287-1294.
[http://dx.doi.org/10.1016/j.jdiacomp.2015.07.013] [PMID: 26264399]

Brock, C.; Hansen, C.S.; Karmisholt, J.; Møller, H.J.; Juhl, A.; Farmer, A.D.; Drewes, A.M.; Riahi, S.; Lervang, H.H.; Jakobsen, P.E.; Brock, B. Liraglutide treatment reduced interleukin‐6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy. Br. J. Clin. Pharmacol., 2019, 85(11), 2512-2523.
[http://dx.doi.org/10.1111/bcp.14063] [PMID: 31338868]

Zavattaro, M.; Caputo, M.; Samà, M.T.; Mele, C.; Chasseur, L.; Marzullo, P.; Pagano, L.; Mauri, M.G.; Ponziani, M.C.; Aimaretti, G.; Prodam, F. One-year treatment with liraglutide improved renal function in patients with type 2 diabetes: a pilot prospective study. Endocrine, 2015, 50(3), 620-626.
[http://dx.doi.org/10.1007/s12020-014-0519-0] [PMID: 25572181]

von Scholten, B.J.; Persson, F.; Rosenlund, S.; Hovind, P.; Faber, J.; Hansen, T.W.; Rossing, P. The effect of liraglutide on renal function: A randomized clinical trial. Diabetes Obes. Metab., 2017, 19(2), 239-247.
[http://dx.doi.org/10.1111/dom.12808] [PMID: 27753201]

Tuttle, K.R.; Lakshmanan, M.C.; Rayner, B.; Busch, R.S.; Zimmermann, A.G.; Woodward, D.B.; Botros, F.T. Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): A multicentre, open-label, randomised trial. Lancet Diabetes Endocrinol., 2018, 6(8), 605-617.
[http://dx.doi.org/10.1016/S2213-8587(18)30104-9] [PMID: 29910024]

Varadhan, L.; Humphreys, T.; Walker, A.B.; Varughese, G.I. The impact of improved glycaemic control with GLP-1 receptor agonist therapy on diabetic retinopathy. Diabetes Res. Clin. Pract., 2014, 103(3), e37-e39.
[http://dx.doi.org/10.1016/j.diabres.2013.12.041] [PMID: 24456992]

Bethel, M.A.; Mentz, R.J.; Merrill, P.; Buse, J.B.; Chan, J.C.; Goodman, S.G.; Iqbal, N.; Jakuboniene, N.; Katona, B.; Lokhnygina, Y.; Lopes, R.D.; Maggioni, A.P.; Ohman, P.; Tankova, T.; Bakris, G.L.; Hernandez, A.F.; Holman, R.R. Microvascular and cardiovascular outcomes according to renal function in patients treated with once-weekly exenatide: Insights from the EXSCEL trial. Diabetes Care, 2020, 43(2), 446-452.
[http://dx.doi.org/10.2337/dc19-1065] [PMID: 31757838]

Rizzo, M.; Rizvi, A.A.; Patti, A.M.; Nikolic, D.; Giglio, R.V.; Castellino, G.; Li Volti, G.; Caprio, M.; Montalto, G.; Provenzano, V.; Genovese, S.; Ceriello, A. Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study. Cardiovasc. Diabetol., 2016, 15(1), 162.
[http://dx.doi.org/10.1186/s12933-016-0480-8] [PMID: 27912784]